The administration of pre-hospital ketamine for chemical restraint does not prolong on-scene times compared to haloperidol based sedation

Aaron M. Burnett, Dolly Panchal, Bjorn Peterson, Eric Ernest, Kent Griffith, Ralph J. Frascone, Kristin Engebretsen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Agitated patients who present a danger to themselves or emergency medical services providers may require chemical restraints. Haloperidol is employed for chemical restraint in many emergency medical services. Recently, ketamine has been introduced as an alternate option for pre-hospital sedation. On-scene time is a unique metric in pre-hospital medicine that has been linked to outcomes in multiple patient populations. When used for chemical restraint, the impact of ketamine relative to haloperidol on onscene time is unknown. Objective To evaluate whether the use of ketamine for chemical restraint was associated with a clinically significant (≥5 minute) increased on-scene time compared to a haloperidol based regimen. Methods Patients who received haloperidol or ketamine for chemical restraint were identified by retrospective chart review. On-scene time was compared between groups using an unadjusted student t-test powered to 80% to detect a ≥5 minute difference in on-scene time. Results 110 cases were abstracted (haloperidol = 55; ketamine = 55). Of the patients receiving haloperidol, 11/55 (20%) were coadministered a benzodiazepine, 4/55 (7%) received diphenhydramine and 34/55 (62%) received the three drugs in combination. There were no demographic differences between the haloperidol and ketamine groups. On-scene time was not statistically different for patients receiving a haloperidol-based regimen compared to ketamine (18.2 minutes, [95% CI: 15.7-20.8] vs. 17.6 minutes, [95% CI: 15.1-20.0]; p=0.71). Conclusion The use of pre-hospital ketamine for chemical restraint was not associated with a clinically significant (≥5 minute) increased onscene time compared to a haloperidol based regimen.

Original languageEnglish (US)
Article number2
JournalAustralasian Journal of Paramedicine
Volume12
Issue number1
StatePublished - Jan 1 2015

Fingerprint

Hospital Administration
Ketamine
Haloperidol
Emergency Medical Services
Hospital Medicine
Diphenhydramine
Drug Combinations
Benzodiazepines
Demography
Students

Keywords

  • Agitation
  • Emergency medical services
  • Haloperidol
  • Ketamine
  • Restraint
  • Sedation

ASJC Scopus subject areas

  • Emergency Medical Services
  • Emergency Medicine
  • Emergency

Cite this

The administration of pre-hospital ketamine for chemical restraint does not prolong on-scene times compared to haloperidol based sedation. / Burnett, Aaron M.; Panchal, Dolly; Peterson, Bjorn; Ernest, Eric; Griffith, Kent; Frascone, Ralph J.; Engebretsen, Kristin.

In: Australasian Journal of Paramedicine, Vol. 12, No. 1, 2, 01.01.2015.

Research output: Contribution to journalArticle

Burnett, Aaron M. ; Panchal, Dolly ; Peterson, Bjorn ; Ernest, Eric ; Griffith, Kent ; Frascone, Ralph J. ; Engebretsen, Kristin. / The administration of pre-hospital ketamine for chemical restraint does not prolong on-scene times compared to haloperidol based sedation. In: Australasian Journal of Paramedicine. 2015 ; Vol. 12, No. 1.
@article{2d586bca51f841dbb043d85530188a10,
title = "The administration of pre-hospital ketamine for chemical restraint does not prolong on-scene times compared to haloperidol based sedation",
abstract = "Background Agitated patients who present a danger to themselves or emergency medical services providers may require chemical restraints. Haloperidol is employed for chemical restraint in many emergency medical services. Recently, ketamine has been introduced as an alternate option for pre-hospital sedation. On-scene time is a unique metric in pre-hospital medicine that has been linked to outcomes in multiple patient populations. When used for chemical restraint, the impact of ketamine relative to haloperidol on onscene time is unknown. Objective To evaluate whether the use of ketamine for chemical restraint was associated with a clinically significant (≥5 minute) increased on-scene time compared to a haloperidol based regimen. Methods Patients who received haloperidol or ketamine for chemical restraint were identified by retrospective chart review. On-scene time was compared between groups using an unadjusted student t-test powered to 80{\%} to detect a ≥5 minute difference in on-scene time. Results 110 cases were abstracted (haloperidol = 55; ketamine = 55). Of the patients receiving haloperidol, 11/55 (20{\%}) were coadministered a benzodiazepine, 4/55 (7{\%}) received diphenhydramine and 34/55 (62{\%}) received the three drugs in combination. There were no demographic differences between the haloperidol and ketamine groups. On-scene time was not statistically different for patients receiving a haloperidol-based regimen compared to ketamine (18.2 minutes, [95{\%} CI: 15.7-20.8] vs. 17.6 minutes, [95{\%} CI: 15.1-20.0]; p=0.71). Conclusion The use of pre-hospital ketamine for chemical restraint was not associated with a clinically significant (≥5 minute) increased onscene time compared to a haloperidol based regimen.",
keywords = "Agitation, Emergency medical services, Haloperidol, Ketamine, Restraint, Sedation",
author = "Burnett, {Aaron M.} and Dolly Panchal and Bjorn Peterson and Eric Ernest and Kent Griffith and Frascone, {Ralph J.} and Kristin Engebretsen",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
volume = "12",
journal = "Australasian Journal of Paramedicine",
issn = "2202-7270",
publisher = "Faculty of Health, Engineering and Science, Edith Cowan University",
number = "1",

}

TY - JOUR

T1 - The administration of pre-hospital ketamine for chemical restraint does not prolong on-scene times compared to haloperidol based sedation

AU - Burnett, Aaron M.

AU - Panchal, Dolly

AU - Peterson, Bjorn

AU - Ernest, Eric

AU - Griffith, Kent

AU - Frascone, Ralph J.

AU - Engebretsen, Kristin

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background Agitated patients who present a danger to themselves or emergency medical services providers may require chemical restraints. Haloperidol is employed for chemical restraint in many emergency medical services. Recently, ketamine has been introduced as an alternate option for pre-hospital sedation. On-scene time is a unique metric in pre-hospital medicine that has been linked to outcomes in multiple patient populations. When used for chemical restraint, the impact of ketamine relative to haloperidol on onscene time is unknown. Objective To evaluate whether the use of ketamine for chemical restraint was associated with a clinically significant (≥5 minute) increased on-scene time compared to a haloperidol based regimen. Methods Patients who received haloperidol or ketamine for chemical restraint were identified by retrospective chart review. On-scene time was compared between groups using an unadjusted student t-test powered to 80% to detect a ≥5 minute difference in on-scene time. Results 110 cases were abstracted (haloperidol = 55; ketamine = 55). Of the patients receiving haloperidol, 11/55 (20%) were coadministered a benzodiazepine, 4/55 (7%) received diphenhydramine and 34/55 (62%) received the three drugs in combination. There were no demographic differences between the haloperidol and ketamine groups. On-scene time was not statistically different for patients receiving a haloperidol-based regimen compared to ketamine (18.2 minutes, [95% CI: 15.7-20.8] vs. 17.6 minutes, [95% CI: 15.1-20.0]; p=0.71). Conclusion The use of pre-hospital ketamine for chemical restraint was not associated with a clinically significant (≥5 minute) increased onscene time compared to a haloperidol based regimen.

AB - Background Agitated patients who present a danger to themselves or emergency medical services providers may require chemical restraints. Haloperidol is employed for chemical restraint in many emergency medical services. Recently, ketamine has been introduced as an alternate option for pre-hospital sedation. On-scene time is a unique metric in pre-hospital medicine that has been linked to outcomes in multiple patient populations. When used for chemical restraint, the impact of ketamine relative to haloperidol on onscene time is unknown. Objective To evaluate whether the use of ketamine for chemical restraint was associated with a clinically significant (≥5 minute) increased on-scene time compared to a haloperidol based regimen. Methods Patients who received haloperidol or ketamine for chemical restraint were identified by retrospective chart review. On-scene time was compared between groups using an unadjusted student t-test powered to 80% to detect a ≥5 minute difference in on-scene time. Results 110 cases were abstracted (haloperidol = 55; ketamine = 55). Of the patients receiving haloperidol, 11/55 (20%) were coadministered a benzodiazepine, 4/55 (7%) received diphenhydramine and 34/55 (62%) received the three drugs in combination. There were no demographic differences between the haloperidol and ketamine groups. On-scene time was not statistically different for patients receiving a haloperidol-based regimen compared to ketamine (18.2 minutes, [95% CI: 15.7-20.8] vs. 17.6 minutes, [95% CI: 15.1-20.0]; p=0.71). Conclusion The use of pre-hospital ketamine for chemical restraint was not associated with a clinically significant (≥5 minute) increased onscene time compared to a haloperidol based regimen.

KW - Agitation

KW - Emergency medical services

KW - Haloperidol

KW - Ketamine

KW - Restraint

KW - Sedation

UR - http://www.scopus.com/inward/record.url?scp=84940646779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940646779&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84940646779

VL - 12

JO - Australasian Journal of Paramedicine

JF - Australasian Journal of Paramedicine

SN - 2202-7270

IS - 1

M1 - 2

ER -